The big-data era has arrived in HIV epidemiology, allowing researchers to better track viruses through communities and the effect of those viruses in communities.
In this interview, we speak to Professor Karsten Borgwardt and Professor Adrian Egli about their latest research that used AI to predict antibiotic resistance.
Many future gene and cell therapies to treat diseases like cancer, rare genetic and other conditions could be enhanced in their efficacy, persistence, and predictability by so-called "genomic safe harbors (GSHs)."
For years, orthopaedic doctors at a government hospital in Bengaluru had noticed that about 11% of their daily patients comprised people who had developed a debilitating bone deformity after going to quacks to treat fractures. In such cases, the only treatment was conventional, inexact surgeries that did not guarantee total success. Now, working with scientists, doctors at
The Basel, Switzerland-based deepCDR team and technology will strengthen Alloy's antibody discovery platform and services for its ecosystem of 100+ global partners Alloy Therapeutics, a biotechnology